Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sulforaphane Use to Effect Inflammatory and Metabolic Changes in Virally Suppressed HIV Patients

NCT05224492 is registered in ClinicalTrials.gov with Sunshine Specialty Health Care as lead sponsor.

NCT NCT05224492
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05224492 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sulforaphane Use to Effect Inflammatory and Metabolic Changes in Virally Suppressed HIV Patients
Lead sponsor
Sunshine Specialty Health Care
Phase
Phase 4
Overall status
Unknown status
Start date
February 21, 2022
Completion date
September 21, 2022
Enrollment
20 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections